Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Results of a study investigating the combination of bendamustine, gemcitabine, and vinorelbine prior to autologous stem cell transplant for treatment of relapsed Hodgkin lymphoma.